Top

Published in:

01-01-2018 | Original Article

Is there a pathological relationship between microalbuminuria and Helicobacter pylori vacA and cagA genes in type 2 diabetic patients?

Authors: Latifeh Abdollahi, Zahra Molabashi, Mehdi Azami, Rasoul Salehi, Seyed Hossein Hejazi, Narghes Abdali

Published in: Comparative Clinical Pathology | Issue 1/2018

Abstract

Diabetes is one of the most common metabolic disorders worldwide. Microalbuminuria, one of the complications following elevated glucose levels, is used as a simple and effective method of kidney function analysis in diabetic patients. Early stage diagnosis of microalbuminuria is useful in monitoring and prevention of the progression of diabetic nephropathy. Due to a lower immunity, diabetic patients are more susceptible. Reports have shown that cytotoxin-associated gene A (cagA)-positive Helicobacter pylori is one of the effective factors responsible in microalbuminuria pathology. However, a lack of information on the relationship between microalbuminuria in type II diabetes and vacuolating cytotoxin A (vacA) is evident. The present study aimed at the relationship between microalbuminuria in type II diabetes and vacA and cagA genes from H. pylori. A total of 88 type II diabetic patients referred to the Isfahan Endocrine and Metabolism Research Center participated in this study. Nested PCR was performed to exclude host genes, and consequently, H. pylori genotyping was performed based on vacA and cagA. Out of the 88 patients, 68.2 % (60/88) of them have microalbuminuria. A total of 18.2 % of the patients were infected with H. pylori in which 75 % of them showed microalbuminuria and 18.8 % of this group had simultaneously microalbuminuria and expression of cagA. The association between microalbuminuria and H. pylori infection was not statistically significant (p = 0.52). Considering the population size and criteria of choice, statistical analysis did not show any significant relationship between the virulence genes vacA and cagA of H. pylori and microalbuminuria in type II diabetic patients.

Abdollahi L, Zolfaghari MR, Amini M, Salehi R (2012) The relation between microalbuminuria and Helicobacter Pylori vacA gene in type 2 diabetic patients, Isfahan, Iran. J Isfahan Med Sch 30(179):228–237

Afkhami Ardekani M, Modarresi M, Amirchaghmaghi E (2004) Prevalence of microalbuminuria and its risk factors in patients with type 2 diabetes. Indian J Nephrol 18(3):112–117CrossRef

Alamdari MI, Aminisani N, Bashardoost B, Shamshirgaran S, Khodamoradzadeh M, Shokrabadi M, Olomi B (2006) Prevalence and risk factors of microalbuminuria in type 2 diabetic patients in a diabetic clinic of Ardabil—Iran. Int J Endocrinol Metab 4(1):8–12

Ariabod V, Tabrizian F, Jalili D, Hakimitabar M (2009) The prevalence and some risk factors of microalbuminuria among type 2 diabetics that referred to a diabetes clinic. J Med Sci Azad Univ Mashhad 5(2):79–84

American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Suppl 1):S67–S74CrossRef

Bener A, Micallef R, Afifi M, Derbala M, AlMulla HM, Usmani MA (2007) Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol 18(4):225–229PubMed

Blaser MJ, Atherton JC (2004) Helicobacter pylori persistence: biology and disease. J Clin Investig 113(3):321–333CrossRefPubMedPubMedCentral

Demir M, Gokturk HS, Ozturk NA, Kulaksizoglu M, Serin E, Yilmaz U (2008) Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci 53(10):2646–2649CrossRefPubMed

Falsafi T, Favaedi R, Mahjoub F, Najafi M (2009) Application of stool-PCR test for diagnosis of Helicobacter pylori infection in children. World J Gastroenterol l15(4):484CrossRef

Farshad S, Japoni A, Alborzi A, Kalani M (2008) Genotyping of Helicobacter pylori strains isolated from patients with gastric ulcer and non ulcer disease using RFLP-PCR of ureAB, vacA, cagA genes. Sci J Hamadan Uni Med Sci 15(3):11–17

International Diabetes Federation (2006) Diabetes atlas. Brussels, Belgium

Godoy AP, Ribeiro ML, Benvengo YH, Vitiello L, Maira de Carvalho BM, Mendonça S, Pedrazzoli J (2003) Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol 3(1):20CrossRefPubMedPubMedCentral

Ibrahim A, Zaher T, Ghonemy T, El-Azim S, El-Azim M, Ramadan A (2010) Impact of cytotoxin-associated gene A of Helicobacter pylori strains on microalbuminuria in type 2 diabetes. Saudi J Kidney Dis Transplant 21(4):694–700

Ko GT, Chan FK, Chan WB, Sung JJ, Tsoi C, To K, Lai C, Cockram CS (2001) Helicobacter pylori infection in Chinese subjects with type 2 diabetes. Endocr Res 27(1–2):171–177CrossRefPubMed

Mikaily J, Malekzadeh R, Ziadalizadeh B, Khoncheh A, Masserat S (1999) Helicobacter pylori prevalence in two Iranian provinces with high and low incidence of gastric carcinoma. Tehran Univ Med J57(1):34–38

Mitchell A, Silva TM, Barrett LJ, Lima AA, Guerrant RL (2003) Age-specific Helicobacter pylori seropositivity rates of children in an impoverished urban area of northeast Brazil. J Clin Microbiol 41(3):1326–1328CrossRefPubMedPubMedCentral

Mojtahedi A, Salehi R, Navabakbar F, Tamizifar H, Andalib A, Safaei H, Tavakkoli H, Farajzadega Z (2007) Apoptosis induction on AGS gastric adenocarcinoma and HEF fibroblast cell lines by wild type and cagA or vacA negative Helicobacter pylori strains. J Sci I R Iran 18(3203):203–208

Mokhtari M (2002) Evaluation of antibody of Helicobacter pylori infection in preschool children in Isfahan. Iran J Gastroentrol 36:33–38

Moradi A, Rashidy-Pour A (2000) Seroepidemiology of Helicobacter pylori infection in Semnan. Koomesh 1(4):53–57

Nakayama K, Negishi I, Kuida K, Sawa H, Loh D (1994) Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Pro Natl Acad Sci U S A 91(9):3700–3704CrossRef

Papazafiropoulou A, Daniil I, Sotiropoulos A, Balampani E, Kokolaki A, Bousboulas S, Konstantopoulou S, Skliros E, Petropoulou D, Pappas S (2010) Prevalence of asymptomatic bacteriuria in type 2 diabetic subjects with and without microalbuminuria. BMC Res Notes 3(1):169CrossRefPubMedPubMedCentral

Pietroiusti A, Giuliano M, Magrini A, Bergamaschi A, Galante A (2006) Cytotoxin-associated gene A strains of Helicobacter pylori represent a risk factor for the development of microalbuminuria in type 2 diabetes. Diabetes Care 29(6):1399–1401CrossRefPubMed

Quadri R, Rossi C, Catalfamo E, Masoero G, Lombardo L, Della Monica P, Rovera L, Pera A, Cavello PP (2000) Helicobacter pylori infection in type 2 diabetic patients. Nutr Metab Cardiovasc 10(5):263–266

Rashki KM, Gol A, Dabiri S (2009) Preventive effects of garlic juice on renal damages induced by diabetes mellitus in rats. Iran J Endocr Metab 11(3):331–339

Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, Giorda C, Valentini U, Vespasiani G, De Cosmo S (2008) Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant 23(4):1278–1284CrossRefPubMed

Salih BA (2009) Helicobacter pylori infection in developing countries: the burden for how long? Saudi J Gastroenterol 15(3):201–207CrossRefPubMedPubMedCentral

Sasaki T, Hirai I, Izurieta R, Kwa BH, Estevez E, Saldana A, Calzada J, Fujimoto S, Yamamoto Y (2009) Analysis of Helicobacter pylori genotype in stool specimens of asymptomatic people. Lab Med 40(7):412–414CrossRef

Schalkwijk C, Stehouwer C (2005) Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 109(2):143–159CrossRefPubMed

Shaw J, Sicree R, Zimmet P (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87(1):4–14CrossRefPubMed

Sicinschi LA, Correa P, Bravo LE, Schneider BG (2003) A positive assay for identification of cagA negative strains of Helicobacter pylori. J Microbiol Method 55(3):625–633CrossRef

Suerbaum S, Michetti P (2002) Helicobacter pylori infection. New Eng J Med 347(15):1175–1186CrossRefPubMed

Supajatura V, Ushio H, Wada A, Yahiro K, Okumura K, Ogawa H, Hirayama T, Ra C (2002) Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 168(6):2603–2607CrossRefPubMed

Talaei A, Jabari S, Bigdeli MH, Farahani H, Siavash M (2011) Correlation between microalbuminuria and urinary copper in type two diabetic patients. Indian J Endocr Metab 15(4):316–319CrossRef

Tanriverdi O (2011) Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients. Turk J Gastroenterol 22(6):569–574CrossRefPubMed

Van Doorn L, Figueiredo C, Rossau R, Jannes G, Van Asbroeck M, Sousa J, Carneiro F, Quint W (1998) Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J Clin Microbiol 36(5):1271–1276PubMedPubMedCentral

Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94(3):311–321CrossRefPubMed

Yazdanpanah K, Rahimi E, Sharifian A, Eishi A (2009) Epidemiology of Helicobacter pylori infection in Kurdistan Province, 2006. Sci J Kurdistan Univ Med Sci 14(1):1–8

Title: Is there a pathological relationship between microalbuminuria and Helicobacter pylori vacA and cagA genes in type 2 diabetic patients?
Authors: Latifeh Abdollahi
Zahra Molabashi
Mehdi Azami
Rasoul Salehi
Seyed Hossein Hejazi
Narghes Abdali
Publication date: 01-01-2018
Publisher: Springer London
Published in: Comparative Clinical Pathology / Issue 1/2018
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI: https://doi.org/10.1007/s00580-014-1916-8

At a glance: The STEP trials

Springer Medicine

Is there a pathological relationship between microalbuminuria and Helicobacter pylori vacA and cagA genes in type 2 diabetic patients?

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Subclinical nodular goiter associated with Hurthle cell, papillary, and adenomatoid hyperplasic nodules in the dromedary camel in the Sultanate of Oman

Retrospective study on the etiology and clinical signs of canine otitis

Phenotypic variation of thymic epithelial cells and partial spontaneous regression in thymoma of a cow

The genetic association of cytokine genes, single nucleotide polymorphisms, and the incidence of liver cirrhosis in chronic hepatitis C Egyptian patients

Serum 8-hydroxydeoxyguanosine and aldose reductase C-106T polymorphism in type 2 diabetes mellitus and its relation to complications in Egyptian patients

Apoptosis induced by Moringa oleifera Lam. pod in mouse colon carcinoma model